The Expression of Involucrin, Loricrin, and Filaggrin in Cultured Sebocytes
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Differential Roles of P63 Isoforms in Epidermal Development: Selective Genetic Complementation in P63 Null Mice
Cell Death and Differentiation (2006) 13, 1037–1047 & 2006 Nature Publishing Group All rights reserved 1350-9047/06 $30.00 www.nature.com/cdd Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice E Candi1, A Rufini1, A Terrinoni1, D Dinsdale2, M Ranalli1, The skin consists of two compartments, the dermis and the A Paradisi1, V De Laurenzi2, LG Spagnoli1, MV Catani1, epidermis. The latter is a multilayered, stratified epithelium S Ramadan1, RA Knight2 and G Melino*,1,2 continuously regenerated by terminally differentiating keratino- cytes, a process called cornification1–3 (Figure 1a and b). 4 1 Biochemistry Laboratory, IDI-IRCCS, c/o University of Rome ‘Tor Vergata’, Recent evidence demonstrates a major role for p63, a 00133 Rome, Italy member of the p53 family,5–8 in this process as mutations in 2 Medical Research Council, Toxicology Unit, Leicester University, Leicester the TP63 gene cause limb and skin defects in humans,9 and LE1 9HN, UK p63À/À mice have no epidermis, no limbs and die at birth * Corresponding author: G Melino, Medical Research Council, Toxicology Unit, owing to dehydration.10,11 Hodgkin Building, Leicester University, Lancaster Road, PO Box 138, Leicester LE1 9HN, UK. Tel: þ 44 116 252 5616; Fax: þ 44 116 252 5551; The expression of p63 proteins originates from two E-mail: [email protected] promoters, giving rise to TAp63 and DNp63 isoforms. In addition, both isoforms undergo alternative splicing at the Received 03.3.06; revised 08.3.06; accepted 08.3.06; published online 07.4.06 C-terminus producing three different TAp63 and DNp63 Edited by P Vandenabeele isoforms (a, b and g). -
Deimination, Intermediate Filaments and Associated Proteins
International Journal of Molecular Sciences Review Deimination, Intermediate Filaments and Associated Proteins Julie Briot, Michel Simon and Marie-Claire Méchin * UDEAR, Institut National de la Santé Et de la Recherche Médicale, Université Toulouse III Paul Sabatier, Université Fédérale de Toulouse Midi-Pyrénées, U1056, 31059 Toulouse, France; [email protected] (J.B.); [email protected] (M.S.) * Correspondence: [email protected]; Tel.: +33-5-6115-8425 Received: 27 October 2020; Accepted: 16 November 2020; Published: 19 November 2020 Abstract: Deimination (or citrullination) is a post-translational modification catalyzed by a calcium-dependent enzyme family of five peptidylarginine deiminases (PADs). Deimination is involved in physiological processes (cell differentiation, embryogenesis, innate and adaptive immunity, etc.) and in autoimmune diseases (rheumatoid arthritis, multiple sclerosis and lupus), cancers and neurodegenerative diseases. Intermediate filaments (IF) and associated proteins (IFAP) are major substrates of PADs. Here, we focus on the effects of deimination on the polymerization and solubility properties of IF proteins and on the proteolysis and cross-linking of IFAP, to finally expose some features of interest and some limitations of citrullinomes. Keywords: citrullination; post-translational modification; cytoskeleton; keratin; filaggrin; peptidylarginine deiminase 1. Introduction Intermediate filaments (IF) constitute a unique macromolecular structure with a diameter (10 nm) intermediate between those of actin microfilaments (6 nm) and microtubules (25 nm). In humans, IF are found in all cell types and organize themselves into a complex network. They play an important role in the morphology of a cell (including the nucleus), are essential to its plasticity, its mobility, its adhesion and thus to its function. -
Cell Shape Controls Terminal Differentiation of Human Epidermal Keratinocytes (Cell Adhesion/Proliferation/Involucrin Expression) FIONA M
Proc. Natl. Acad. Sci. USA Vol. 85, pp. 5576-5580, August 1988 Cell Biology Cell shape controls terminal differentiation of human epidermal keratinocytes (cell adhesion/proliferation/involucrin expression) FIONA M. WATT*, PETER W. JORDANt, AND CHARLES H. O'NEILLt *Keratinocyte Laboratory, and tAnchorage Laboratory, Imperial Cancer Research Fund, P.O. Box 123, Lincoln's Inn Fields, London WC2A 3PX, United Kingdom Communicated by Howard Green, May 2, 1988 ABSTRACT Cultures of human epidermal keratinocytes To investigate the role of cell-substratum contact, and provide a useful experimental model with which to study the hence cell shape, in regulating terminal differentiation, we factors that regulate cell proliferation and terminal differen- have made use of a recently described technique that allows tiation. One situation that is known to trigger premature precise control of cell-substratum contact in the absence of terminal differentiation is suspension culture, when keratin- cell-cell contact (14). We have looked at the effect ofchanges ocytes are deprived of substratum and intercellular contact. in cell shape on DNA synthesis and involucrin expression We have now investigated whether area ofsubstratum contact, and conclude that a rounded morphology acts as a signal to and hence cell shape, can regulate terminal differentiation. keratinocytes to stop dividing and to undergo terminal Keratinocytes were grown on circular adhesive islands that differentiation; inhibition ofproliferation in spread cells is not prevented cell-cell contact. By varying island area we could a sufficient signal for terminal differentiation. vary cell shape from fully spread to almost spherical. We found that when substratum contact was restricted, DNA synthesis was inhibited and expression of involucrin, a marker of MATERIALS AND METHODS terminal differentiation, was stimulated. -
Germline Variants in Driver Genes of Breast Cancer and Their Association with Familial and Early-Onset Breast Cancer Risk in a Chilean Population
cancers Article Germline Variants in Driver Genes of Breast Cancer and Their Association with Familial and Early-Onset Breast Cancer Risk in a Chilean Population Alejandro Fernandez-Moya 1, Sebastian Morales 1,* , Trinidad Arancibia 1, Patricio Gonzalez-Hormazabal 1, Julio C. Tapia 2, Raul Godoy-Herrera 1, Jose Miguel Reyes 3, Fernando Gomez 4, Enrique Waugh 4 and Lilian Jara 1,* 1 Programa de Genética Humana, Instituto de Ciencia Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile; [email protected] (A.F.-M.); [email protected] (T.A.); [email protected] (P.G.-H.); [email protected] (R.G.-H.) 2 Laboratorio de Transformación Celular, Departamento de Oncología Básico Clínica, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile; [email protected] 3 Clínica Las Condes, Santiago 7591047, Chile; [email protected] 4 Clínica Santa María, Santiago 7520378, Chile; [email protected] (F.G.); [email protected] (E.W.) * Correspondence: [email protected] (S.M.); [email protected] (L.J.); Tel.: +56-9-98292094 (L.J.) Received: 11 September 2019; Accepted: 19 November 2019; Published: 20 January 2020 Abstract: The genetic variations responsible for tumorigenesis are called driver mutations. In breast cancer (BC), two studies have demonstrated that germline mutations in driver genes linked to sporadic tumors may also influence BC risk. The present study evaluates the association between SNPs and SNP-SNP interaction in driver genes TTN (rs10497520), TBX3 (rs2242442), KMT2D (rs11168827), and MAP3K1 (rs702688 and rs702689) with BC risk in BRCA1/2-negative Chilean families. The SNPs were genotyped in 489 BC cases and 1078 controls by TaqMan Assay. -
MALE Protein Name Accession Number Molecular Weight CP1 CP2 H1 H2 PDAC1 PDAC2 CP Mean H Mean PDAC Mean T-Test PDAC Vs. H T-Test
MALE t-test t-test Accession Molecular H PDAC PDAC vs. PDAC vs. Protein Name Number Weight CP1 CP2 H1 H2 PDAC1 PDAC2 CP Mean Mean Mean H CP PDAC/H PDAC/CP - 22 kDa protein IPI00219910 22 kDa 7 5 4 8 1 0 6 6 1 0.1126 0.0456 0.1 0.1 - Cold agglutinin FS-1 L-chain (Fragment) IPI00827773 12 kDa 32 39 34 26 53 57 36 30 55 0.0309 0.0388 1.8 1.5 - HRV Fab 027-VL (Fragment) IPI00827643 12 kDa 4 6 0 0 0 0 5 0 0 - 0.0574 - 0.0 - REV25-2 (Fragment) IPI00816794 15 kDa 8 12 5 7 8 9 10 6 8 0.2225 0.3844 1.3 0.8 A1BG Alpha-1B-glycoprotein precursor IPI00022895 54 kDa 115 109 106 112 111 100 112 109 105 0.6497 0.4138 1.0 0.9 A2M Alpha-2-macroglobulin precursor IPI00478003 163 kDa 62 63 86 72 14 18 63 79 16 0.0120 0.0019 0.2 0.3 ABCB1 Multidrug resistance protein 1 IPI00027481 141 kDa 41 46 23 26 52 64 43 25 58 0.0355 0.1660 2.4 1.3 ABHD14B Isoform 1 of Abhydrolase domain-containing proteinIPI00063827 14B 22 kDa 19 15 19 17 15 9 17 18 12 0.2502 0.3306 0.7 0.7 ABP1 Isoform 1 of Amiloride-sensitive amine oxidase [copper-containing]IPI00020982 precursor85 kDa 1 5 8 8 0 0 3 8 0 0.0001 0.2445 0.0 0.0 ACAN aggrecan isoform 2 precursor IPI00027377 250 kDa 38 30 17 28 34 24 34 22 29 0.4877 0.5109 1.3 0.8 ACE Isoform Somatic-1 of Angiotensin-converting enzyme, somaticIPI00437751 isoform precursor150 kDa 48 34 67 56 28 38 41 61 33 0.0600 0.4301 0.5 0.8 ACE2 Isoform 1 of Angiotensin-converting enzyme 2 precursorIPI00465187 92 kDa 11 16 20 30 4 5 13 25 5 0.0557 0.0847 0.2 0.4 ACO1 Cytoplasmic aconitate hydratase IPI00008485 98 kDa 2 2 0 0 0 0 2 0 0 - 0.0081 - 0.0 -
Mutant‑Allele Tumor Heterogeneity in Malignant Glioma Effectively Predicts Neoplastic Recurrence
6108 ONCOLOGY LETTERS 18: 6108-6116, 2019 Mutant‑allele tumor heterogeneity in malignant glioma effectively predicts neoplastic recurrence PENGFEI WU, WEI YANG, JIANXING MA, JINGYU ZHANG, MAOJUN LIAO, LUNSHAN XU, MINHUI XU and LIANG YI Department of Neurosurgery, Daping Hospital and Institute Research of Surgery, Army Medical University, Chongqing 400042, P.R. China Received March 13, 2019; Accepted September 6, 2019 DOI: 10.3892/ol.2019.10978 Abstract. Intra-tumor heterogeneity (ITH) is one of the most RFS of patients with glioma. In conclusion, the MATH value important causes of therapy resistance, which eventually of a patient may be an independent predictor that influences leads to the poor outcomes observed in patients with glioma. glioma recurrence. The nomogram model presented in the Mutant-allele tumor heterogeneity (MATH) values are based current study was an appropriate method to predict 1-, 2- and on whole‑exon sequencing and precisely reflect genetic ITH. 5-year RFS probabilities in patients with glioma. However, the significance of MATH values in predicting glioma recurrence remains unclear. Information of patients Introduction with glioma was obtained from The Cancer Genome Atlas database. The present study calculated the MATH value for Glioma is the most common primary malignant tumor in each patient, analyzed the distributions of MATH values the central nervous system (1). Despite surgery and radio- in different subtypes and investigated the rates of clinical therapy, chemotherapy and targeted therapy, the majority of recurrence in patients with different MATH values. Gene malignant gliomas still recur (2,3), which is primarily due enrichment and Cox regression analyses were performed to to chemo-radiotherapy resistance (4). -
Cutaneous Manifestations of Systemic Disease
Updates on Canine Atopic Dermatitis Karen L. Campbell, DVM, MS, DACVIM, DACVD Professor Emerita, University of Illinois Clinical Professor of Dermatology, University of Missouri Allergies in dogs Atopic Dermatitis • Affects 10-15% of dogs • Pathogenesis – Genetics – Immunological – Structural • Risk factors – Breed – Environment – Birthdate Implications: not a homogenous disease—many factors involved Genetics of Atopic Dermatitis • Breeds predisposed • Terriers, setters, beagles, boxers, Lhaso Apso, pug, bulldogs, miniature schnauzer, retrievers, Dalmatian, GSD, others • Breeding study (labs, retrievers) • 2 atopic parents: 65% offspring atopic • 1 atopic 1 normal: 57% offspring atopic • 2 normal parents: 11% offspring atopic Implication – ideal not to breed affected dogs Gene Mutations & AD • Filaggrin • Plakophilin 2 • SPINK5 • PPARγ • IgA deficiency (GSD) • Pro-inflammatory • S100A8 • INPPL1 • DPP4 Marsella R et al: TEM studies in experimental model of K9 AD. Vet Derm 21:81-88, 2010. Implications: not a homogenous disease, many targets for treatment, effectiveness of treatment may vary depending on cause in the individual dog Skin Barrier Dysfunction in AD Immunology of Atopy • Allergen exposure • Predominantly percutaneous • Increased absorption of allergens in dogs with defective skin barrier function • Antigen Processing Cells: • Langerhans cells and keratinocytes in skin • Present antigens to T- helper and B-cells to stimulate Ig production • Sites of Ig production • regional lymph nodes Immunological Imbalances in Atopy • Increased -
The Human Involucrin Gene Contains Spatially Distinct Regulatory Elements That Regulate Expression During Early Versus Late Epidermal DiErentiation
Oncogene (2002) 21, 738 ± 747 ã 2002 Nature Publishing Group All rights reserved 0950 ± 9232/02 $25.00 www.nature.com/onc The human involucrin gene contains spatially distinct regulatory elements that regulate expression during early versus late epidermal dierentiation James F Crish1, Frederic Bone1, Eric B Banks1 and Richard L Eckert*,1,2,3,4,5 1Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, 2109 Adelbert Road, Cleveland, Ohio, OH 44106-4970, USA; 2Department of Dermatology, Case Western Reserve University School of Medicine, 2109 Adelbert Road, Cleveland, Ohio, OH 44106-4970, USA; 3Department of Reproductive Biology, Case Western Reserve University School of Medicine, 2109 Adelbert Road, Cleveland, Ohio, OH 44106-4970, USA; 4Department of Biochemistry, Case Western Reserve University School of Medicine, 2109 Adelbert Road, Cleveland, Ohio, OH 44106-4970, USA; 5Department of Oncology, Case Western Reserve University School of Medicine, 2109 Adelbert Road, Cleveland, Ohio, OH 44106-4970, USA Human involucrin (hINV) is a keratinocyte protein that Keywords: transgenic mice; activator protein-1; AP1; is expressed in the suprabasal compartment of the jun; fos; Sp1; gene regulation; epidermal keratinocyte; epidermis and other stratifying surface epithelia. In- keratinocyte dierentiation; tissue speci®c volucrin gene expression is initiated early in the dierentiation process and is maintained until terminal cell death. The distal regulatory region (DRR) is a Introduction segment of the hINV promoter (nucleotides 72473/ 71953) that accurately recapitulates the normal pattern The major cell type, and the cell type responsible for of suprabasal (spinous and granular layer) expression in the morphological characteristics of the epidermis, is transgenic mouse epithelia. -
Supplementary Table 1
Supplementary Table 1. 492 genes are unique to 0 h post-heat timepoint. The name, p-value, fold change, location and family of each gene are indicated. Genes were filtered for an absolute value log2 ration 1.5 and a significance value of p ≤ 0.05. Symbol p-value Log Gene Name Location Family Ratio ABCA13 1.87E-02 3.292 ATP-binding cassette, sub-family unknown transporter A (ABC1), member 13 ABCB1 1.93E-02 −1.819 ATP-binding cassette, sub-family Plasma transporter B (MDR/TAP), member 1 Membrane ABCC3 2.83E-02 2.016 ATP-binding cassette, sub-family Plasma transporter C (CFTR/MRP), member 3 Membrane ABHD6 7.79E-03 −2.717 abhydrolase domain containing 6 Cytoplasm enzyme ACAT1 4.10E-02 3.009 acetyl-CoA acetyltransferase 1 Cytoplasm enzyme ACBD4 2.66E-03 1.722 acyl-CoA binding domain unknown other containing 4 ACSL5 1.86E-02 −2.876 acyl-CoA synthetase long-chain Cytoplasm enzyme family member 5 ADAM23 3.33E-02 −3.008 ADAM metallopeptidase domain Plasma peptidase 23 Membrane ADAM29 5.58E-03 3.463 ADAM metallopeptidase domain Plasma peptidase 29 Membrane ADAMTS17 2.67E-04 3.051 ADAM metallopeptidase with Extracellular other thrombospondin type 1 motif, 17 Space ADCYAP1R1 1.20E-02 1.848 adenylate cyclase activating Plasma G-protein polypeptide 1 (pituitary) receptor Membrane coupled type I receptor ADH6 (includes 4.02E-02 −1.845 alcohol dehydrogenase 6 (class Cytoplasm enzyme EG:130) V) AHSA2 1.54E-04 −1.6 AHA1, activator of heat shock unknown other 90kDa protein ATPase homolog 2 (yeast) AK5 3.32E-02 1.658 adenylate kinase 5 Cytoplasm kinase AK7 -
Characterization of the Human Involucrin Promoter Using a Transient -Galactosidase Assay
Journal of Cell Science 103, 925-930 (1992) 925 Printed in Great Britain © The Company of Biologists Limited 1992 Characterization of the human involucrin promoter using a transient -galactosidase assay JOSEPH M. CARROLL1 and LORNE B. TAICHMAN2,* 1Graduate Program in Cellular and Developmental Biology, 2Department of Oral Biology and Pathology, School of Dental Medicine, State University of New York at Stony Brook, Stony Brook, New York 11794-8702, USA *Author for correspondence Summary Involucrin, a component of the cornified cell envelope, nascent RNA and suggested that sequences within the is expressed specifically in differentiating keratinocytes intron have regulatory activity. These results suggest of stratified squamous epithelia. To explore the regula- that the involucrin intron operates in vivo to regulate tion of involucrin expression, 3.7 kb of upstream expression in the epidermis. sequences of the human involucrin gene was cloned into a plasmid containing a -galactosidase reporter gene and transfected into early passage keratinocytes and a Abbreviations used: ADH, alcohol dehydrogenase; b-gal, b- galactosidase; DME, Dulbecco’s modified Eagle’s medium; variety of human cell types. The full-length construct DDAB, dimethyldioctyldecylammonium bromide; FCS, fetal calf gave maximal and tissue-specific expression. Deletion serum; kb, kilobase; ONPG, O-nitrophenyl b-D- analysis showed that sequences between 900 and 2500 galactopyranoside; PBS, phosphate buffered saline without bp upstream of the transcriptional start site and the calcium/magnesium salts; PCR, polymerase chain reaction; intron located between the transcriptional and transla- PtdEtn, dioleoyl-L-a -phosphatidylethanolamine; RSV, Rous tional start sites were required for maximal expression. sarcoma virus; SV40, simian virus 40. -
Involucrin - Structure and Role in Envelope Assembly
REVIEW Involucrin - Structure and Role in Envelope Assembly Richard L. Eckert, Michael B. Yaffe,james F. Crish, Shubha Murthy, Ellen A. Rorke, and Jean F. Welter Departments of Physiology and Biophysics (RLE, MBY, JFC, SM, EAR, JFW), Dermatology (RLE), Reproductive Biology (RLE), Biochemistry (RLE), and EnvI ronmental Health SCIences (EAR) , Case Western Reserve UniverSIty School of MedIcine, Cleveland, Ohio, U .S.A. he epidermis is elegantly designed to provide a con 'from cultured keratinocytes or fibroblasts [23] . This transfer is cal stantly renewing protective surface. The proliferating cium dependent and inhibited by TG inhibitors. Human involucrin stem cel ls, which constantly replenish the epidermis, has also been expressed in cultured rat keratinecytes, CHO cells, occupy the basal layer adjacent the basal lamina [1,2]. and PtK2 cells via vector-mediated gene transfer [24]. Elevation of The supra basal spinous and granular la yers contain intracellular calcium resulted in the disappearance of human inve T11s that have largely lost proliferative potential, but are still living lucrin frem the soluble phase in cells expressing keratinecyte (rat ce d functioning. These cells are undergoing a progressive process of ~eratinocytes) and tissue-type (CHO cell s) transglutaminase, respec ~ntrac ellular remodeling in preparation for terminal differentiation. tIvely [24]. In each case the disappea rance was inhibitable by cal r the stratum lucidum the remodeling is largely completed as the cium chelators or TG inhibitors. No disappearance from the soluble : ratinocytes pass from the living to the non-living state to form phase was observed in PtK2 cells, which express barely detectab le e neocytes [1,2]. -
Codon Reiteration and the Evolution of Proteins
Proc. Nati. Acad. Sci. USA Vol. 91, pp. 4298-4302, May 1994 Evolution Codon reiteration and the evolution of proteins HOWARD GREEN AND NORMAN WANG Department of Cell Biology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115 Contributed by Howard Green, January 18, 1994 ABSTRACT Sequence data banks have been searched for dropped out, leaving few reiterants of hydrophobic amino proteins possessing uninterrupted reiterations of any amino acids. There is no reiterant of arginine. acid. Hydrophilic amino acids, and particularly glutamine, Among reiterants containing 20 or more residues, gluta- account for a large proportion of the longer reiterants. In the mine is clearly dominant and accounts for half of all reiter- genes for these proteins, the most common reiterants are those ants. The other nine amino acid residues found in reiterants that contain poly(CAG), even out-of-frame or, to a lesser are mainly hydrophilic. degree, those that contain repeated doublets ofCA, AG, or GC. The preferential generation of such reiterants requires that Codons Responsible for Reiterants of 10 or More Amino DNA strand-specific signals predispose to reiteration and thus Acid Residues to the extension of coding regions. Of the 229 reiterants, there are only 48 that are encoded by Sequences consisting of multiple consecutive residues of a uninterrupted reiterations of a single codon; most of the single amino acid (reiterants) are not rare in proteins. For amino acid reiterants are the result of mixed synonymous example, reiterants consisting of glutamine residues, most codons. Probably some of these were originally reiterants of often encoded by CAG, were first discovered in homeotic a single codon, but nucleotide substitutions have since oc- proteins (1-3) and later in other transcription factors.